2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decker, M; Edenharder, R; Kayser, O; Kolodziej, H; Platt, KL; Speth, C | 1 |
| Darroudi, F; Knasmüller, S; Nagao, M; Parzefall, W; Sanyal, R | 1 |
2 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and warfarin
| Article | Year |
|---|---|
Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones.
Topics: Chromones; Coumarins; Drug Antagonism; Furans; Mutagenicity Tests; Mutagens; Quinolines; Salmonella typhimurium; Structure-Activity Relationship | 1995 |
Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens.
Topics: Acrolein; Amines; Antimutagenic Agents; Benzaldehydes; Caffeine; Carbolines; Carcinoma, Hepatocellular; Coumarins; DNA Repair; Heterocyclic Compounds; Humans; Hydrolyzable Tannins; Imidazoles; Micronucleus Tests; Mutagens; Quinolines; Tumor Cells, Cultured | 1997 |